Turn Therapeutics (TTRX)

Turn Therapeutics on one page: short interest, daily short volume, fails to deliver, large holders, 13F holders, earnings dates and insider trades. Listed on Nasdaq.

Download CSV

431K

Short interest

settlement 2026-10-15

4.3

Days to cover

+2.9 days vs prior

81.1%

Short share of volume

2026-11-02

5,157

Fails to deliver

settlement 2026-10-09

Thu 12 Nov

Next earnings

estimated date

Insider flow, 90 days

0 buys, 0 sells

As of 2026-11-02.

Short interest

FINRA, twice a month. The newest 25 settlements in the table, 25 in the chart. JSON

As of 15 October 2026, short interest in TTRX is 431,200 shares, up 276,828 shares over the last month. Over the last 25 readings it ranged from 5,671 shares (15 December 2025) to 431,200 shares (15 October 2026). The latest reading sits at the top of that range. At the reported average volume of 101K shares a day that is 4.3 days to cover.

Embed this chart.The embed keeps its attribution line.

<iframe src="https://xoomar.com/embed/stocks/ttrx" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>

Preview Dark previewAdd ?theme=dark to the src for a dark chart.

Settlement	Shares short	Change	Avg daily volume	Days to cover
2026-10-15	431,200	+60.4%	101,360	4.25
2026-09-30	268,757	+74.1%	201,829	1.33
2026-09-15	154,372	+16.3%	135,386	1.14
2026-08-31	132,779	+15.6%	41,383	3.21
2026-08-14	114,828	+36.2%	58,949	1.95
2026-07-31	84,329	+46.1%	90,456	1.00
2026-07-15	57,729	+49.9%	167,824	1.00
2026-06-30	38,506	+25.5%	41,675	1.00
2026-06-15	30,684	-51.9%	72,651	1.00
2026-05-29	63,729	-1.4%	65,133	1.00
2026-05-15	64,613	+25.7%	22,950	2.82
2026-04-30	51,417	-14.6%	20,755	2.48
2026-04-15	60,219	-4.6%	35,226	1.71
2026-03-31	63,128	-4.4%	20,205	3.12
2026-03-13	66,046	-6.7%	19,716	3.35
2026-02-27	70,807	-8.0%	15,758	4.49
2026-02-13	76,967	-5.7%	22,423	3.43
2026-01-30	81,599	+16.6%	39,722	2.05
2026-01-15	69,954	+15.2%	64,045	1.09
2025-12-31	60,709	+970.5%	74,804	1.00
2025-12-15	5,671	-76.7%	65,695	1.00
2025-11-28	24,347	-54.5%	130,042	1.00
2025-11-14	53,542	-47.2%	75,446	1.00
2025-10-31	101,458	-20.2%	170,102	1.00
2025-10-15	127,098	+100.0%	2,015,512	1.00

Daily short volume

FINRA Reg SHO, the last 30 sessions. JSON

As of 2 November 2026, the short share of TTRX volume is 81.1%, up 12.5 points over the last five sessions. Over the last 30 readings it ranged from 36.9% (13 October 2026) to 94.8% (21 October 2026). The latest reading is 8.4 points above the 30-session average of 72.7%, on 35K shares reported.

Date	Short volume	Total volume	Short share	Exempt
2026-11-02	28K	35K	81.1%	246
2026-10-30	27K	43K	62.2%	1,277
2026-10-29	33K	42K	78.5%	0
2026-10-28	10K	15K	67.1%	279
2026-10-27	26K	39K	66.7%	0
2026-10-26	31K	45K	68.6%	0
2026-10-23	28K	39K	70.4%	116
2026-10-22	24K	41K	58.2%	0
2026-10-21	23K	24K	94.8%	0
2026-10-20	11K	25K	44.2%	0
2026-10-19	6K	9K	66.0%	8
2026-10-16	19K	29K	65.1%	144
2026-10-15	28K	36K	76.7%	0
2026-10-14	18K	25K	72.0%	0
2026-10-13	15K	41K	36.9%	0
2026-10-12	15K	18K	80.7%	0
2026-10-09	51K	54K	94.1%	0
2026-10-08	36K	43K	84.1%	0
2026-10-07	42K	49K	86.0%	0
2026-10-06	14K	18K	76.3%	0
2026-10-05	34K	41K	82.3%	0
2026-10-02	55K	69K	79.7%	0
2026-10-01	39K	52K	74.4%	0
2026-09-30	27K	32K	84.1%	0
2026-09-29	26K	31K	82.7%	0
2026-09-28	14K	22K	62.1%	0
2026-09-25	23K	33K	70.4%	624
2026-09-24	53K	84K	62.3%	3,061
2026-09-23	33K	37K	89.0%	0
2026-09-22	34K	54K	63.4%	0

Fails to deliver

SEC, the last 30 settlement dates with a fail. JSON

As of 9 October 2026, the fails-to-deliver balance in TTRX is 5,157 shares, up 5,069 shares over the last settlement date. Over the last 30 readings it ranged from 2 shares (27 August 2026) to 19,577 shares (21 September 2026).

Settlement	Shares failed	Price	Value
2026-10-09	5,157	$11.39	$59K
2026-10-01	88	$14.39	$1K
2026-09-24	720	$13.51	$10K
2026-09-23	719	$15.29	$11K
2026-09-22	15,712	$15.34	$241K
2026-09-21	19,577	$14.94	$292K
2026-09-18	136	$13.82	$2K
2026-09-17	7,646	$13.72	$105K
2026-09-16	339	$13.46	$5K
2026-09-15	289	$13.45	$4K
2026-09-11	1,772	$13.38	$24K
2026-08-27	2	$9.63	$19
2026-08-06	786	$9.43	$7K
2026-07-28	5,445	$7.78	$42K
2026-07-27	2,290	$8.54	$20K
2026-07-21	6,632	$10.05	$67K
2026-07-20	8,774	$9.12	$80K
2026-07-15	5,036	$9.64	$49K
2026-07-02	80	$6.85	$548
2026-07-01	72	$7.30	$526
2026-06-30	903	$6.91	$6K
2026-06-22	253	$5.87	$1K
2026-05-15	283	$4.02	$1K
2026-03-27	9,000	$3.40	$31K
2026-02-24	85	$3.44	$292
2026-02-23	1,398	$3.49	$5K
2026-01-30	4,622	$4.35	$20K
2026-01-29	7,000	$4.57	$32K
2026-01-28	12,378	$4.88	$60K
2026-01-27	11,990	$4.96	$59K

Insider trades

SEC Form 4, newest first. JSON

No open-market insider trades were reported for TTRX in the last 90 days. The most recent filings are listed below. Latest filing: Burnam Bradley Evan (Chief Executive Officer) on 2026-05-28.

Date	Insider	Title	Type	Shares	Price	Value	Owned after
2026-05-28	Burnam Bradley Evan	Chief Executive Officer	Gift	300K	$0.00	$0	300K
2026-05-28	Burnam Bradley Evan	Chief Executive Officer	Gift	300K	$0.00	$0	15.1M
2026-05-28	Burnam Bradley Evan	Chief Executive Officer	Gift	300K	$0.00	$0	300K
2026-05-28	Burnam Bradley Evan	Chief Executive Officer	Gift	300K	$0.00	$0	15.4M
2026-04-02	BEB Holdings, LLC	TenPercentOwner	Gift	300K	$0.00	$0	15.7M
2026-04-02	GOLDEN ARTHUR F	Director	Gift	300K	$0.00	$0	361K
2026-04-02	Burnam Bradley Evan	Chief Executive Officer	Gift	300K	$0.00	$0	15.7M
2026-01-07	Dewhurst Martin William	Director	Grant	22K	$0.00	$0	22K
2025-12-12	Chaudhary Zuraiz	See Remarks	Buy	3K	$3.50	$9K	13K
2025-11-24	GOLDEN ARTHUR F	Director	Buy	10K	$3.44	$34K	61K
2025-11-21	Chaudhary Zuraiz	See Remarks	Buy	1K	$3.29	$3K	10K
2025-11-21	GOLDEN ARTHUR F	Director	Buy	21K	$2.87	$59K	51K
2025-11-20	Chaudhary Zuraiz	See Remarks	Buy	1K	$2.61	$4K	9K
2025-11-17	Chaudhary Zuraiz	See Remarks	Buy	3K	$3.62	$9K	8K
2025-10-23	GOLDEN ARTHUR F	Director	Buy	20K	$4.95	$100K	30K
2025-10-23	Chaudhary Zuraiz	See Remarks	Buy	5K	$4.95	$25K	5K
2025-10-23	Chesed Abraham	Board Observer	Buy	14K	$4.60	$66K	1.4M
2025-10-08	Kester Kent Edward	Director	Grant	10K	$0.00	$0	10K
2025-10-08	Ghodadra Neilesh Shailesh	Chief Medical Officer	Grant	10K	$0.00	$0	10K
2025-10-08	Gengos Andrew	Director	Grant	10K	$0.00	$0	10K
2025-10-08	GOLDEN ARTHUR F	Director	Grant	10K	$0.00	$0	10K

Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.

Large holders (13D and 13G)

One row per reporting person with its latest filing, newest first. JSON

1 holder reports 5% or more of TTRX in its latest filing, on Schedule 13G (passive). The holder is Bradley Burnam at 52.8% of the class (15,716,260 shares), filed 2026-04-06 for an event on 2025-12-31.

Filed	Form	Holder	Shares	Of class	Event
2026-04-06	13G	Bradley Burnamindividual	15.7M	52.8%	2025-12-31

13F holders

Tracked managers holding TTRX at their latest 13F. JSON

2 of the 30 tracked managers held TTRX at their latest 13F, $631K in total at quarter-end prices. Millennium Management is the largest at $442K (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 1 added shares and 1 cut.

Fund	Quarter	Shares	Value	Of portfolio	Change in shares
Millennium Management	2026-06-30	61K	$442K	0.00%	-9K
Citadel Advisors	2026-06-30	26K	$189K	0.00%	new

Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.

What this page is

Turn Therapeutics in the regulatory record

Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.

Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.

This page follows Turn Therapeutics (TTRX), SEC CIK 2023016, listed on Nasdaq. The cross-market tables live on the short interest and insider transactions hubs.

Source and updates

Short interest: FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-10-15.JSON and CSV
Daily short volume: FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-11-02.JSON and CSV
Fails to deliver: SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-10-09.JSON and CSV
Large holders: SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-04-06.JSON and CSV
13F holders: SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
Earnings dates: SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-08-12.JSON and CSV
Insider trades: SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-05-28.JSON and CSV
Company record: EDGAR filing index for CIK 2023016Ticker, name and exchange from the SEC's company list, refreshed weekly.
Rate limits: 10 requests a minute without a key, 30 with a free key from a free account.

How to read it

Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.

Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.

Datasets

Frequently Asked Questions

How much of TTRX is sold short?

431,200 shares were held short at the 2026-10-15 settlement, 4.3 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.

What is TTRX's daily short volume?

On 2026-11-02, 28,277 of the 34,858 TTRX shares reported to FINRA were sold short, 81.1% of the day's reported volume. Short volume is a flow for one day, not a position.

Does TTRX have fails to deliver?

The SEC's latest file shows 5,157 TTRX shares failed to deliver at settlement 2026-10-09. Fails are reported per settlement date and published twice a month with a lag.

Are TTRX insiders buying or selling?

No open-market insider trades were reported for TTRX in the last 90 days. The most recent filings are listed below. Latest filing: Burnam Bradley Evan (Chief Executive Officer) on 2026-05-28.

Who owns 5% or more of TTRX?

Which tracked 13F managers own TTRX?

2 of the 30 tracked 13F managers held TTRX shares at their latest filing, $631K in all. The largest: Izzy Englander's Millennium Management (61K shares, $442K), Ken Griffin's Citadel Advisors (26K shares, $189K).

Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.

Turn Therapeutics (TTRX)

Short interest

Daily short volume

Fails to deliver

Insider trades

Large holders (13D and 13G)

13F holders

Turn Therapeutics in the regulatory record

Source and updates

How to read it

Other company pages

Datasets

Frequently Asked Questions